4.5 Article

Transforming growth factor-beta signaling in breast cancer

Journal

FRONTIERS IN BIOSCIENCE-LANDMARK
Volume 12, Issue -, Pages 4393-4401

Publisher

FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/2396

Keywords

TGF-beta ligand; TGF-beta receptor; cancer therapy; mammary gland; tumor-associated macrophages; breast cancer; animal model; Smad protein; tumor suppressor; tumor promotion; and review

Ask authors/readers for more resources

Transforming growth factor-beta (TGF-beta) is a multifunctional polypeptide that regulates cell growth, differentiation, and extracellular matrix formation. Studies on genetically engineered animal models have demonstrated that TGF-beta-mediated signaling pathway plays a critical role in both normal development and tumorigenesis of the breast. In pathogenesis of breast cancer, the role of TGF-beta appears featured with growth-inhibitory effects at early stages of carcinogenesis, but aggressive oncogenesis with transition to more advanced malignant states. The TGF-beta signaling pathway is also tissue-context and ligand content-dependent. Therein, therapeutic modulation of TGF-beta signaling may be a multifactorial event.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available